“Imaging at a one-hour time point due to the isotope half-life or product shelf-life, as opposed to patient needs, significantly impacts patient care. Firstly, the scheduling of patients may represent a challenge due to the lack of flexibility for imaging. But importantly, later time-point imaging presents significant benefits for doing what cancer diagnostics need to do, and that is finding cancer."
CU6 Price at posting:
$6.39 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)